DSM Venturing

DSM Venturing is an active investor in start-up companies, which create innovative products and services in life sciences. Since its inception in 2001, DSM Venturing, the outside-in arm of their open innovation approach, has invested in more than fifty emerging innovative companies in the US, Europe and Israel. Their primary goal remains to create strategic options and value for DSM and the ecosystem they live in. At the same time, venture grade investment returns are necessary to enable them to do so sustainably.

Rob Beudeker

Investment Director

PH

Philip Hul

Finance Director

Luda Kopeikina

Investment Director

Akshat Kshetrapal

Investment Director

Greg McParland

Investment Director

Arpesh Mehta

Investment Director

Philip Mertens

Associate

Erik Rutten

Senior Investment Manager

Pieter Wolters

MD

75 past transactions

inne

Series A in 2022
Inne is a Berlin-based biotech startup that builds a hormone-based mini lab for women with a mission to make natural contraception convenient and accurate. They aim to help women tune into their bodies and make informed decisions about their fertility and overall female health. Inne uses biochemistry and an app to track hormones and understand what it means and how they affect a woman's everyday fertility.

Prenexus Health

Series B in 2021
Prenexus Health is a prebiotic ingredient manufacturer focused on digestive health and wellness through the research, development and production of branded prebiotic ingredients for vitamin, dietary supplement, food and beverage products. As a science-based company, Prenexus Health is an innovative global leader in prebiotics supported by scientific and clinical research with an emphasis in digestive and microbiome health.

Optiva

Series C in 2003
Optiva is leading the telco industry and its innovative customers around the world by offering next-generation software solutions.

Brains Bioceutical Corp.

Series A in 2021
Brains Bioceutical Corp. engages in the production of naturally-sourced active pharmaceutical ingredients (API) for the pharmaceutical and nutraceutical industries. The company offers CBD oil, capsules, balm, and spray. It serves pharmaceutical; health and wellness; skin and beauty; and veterinary sectors. The company is based in Vancouver, Canada.

NutriLeads

Series A in 2017
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

Hyalex Orthopaedics

Series A in 2019
Hyalex Orthopaedics is a Lexington, MA medical device company advancing new products that feature HYALEX™ materials technology, a polymer that is designed to mimic cartilage. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics' products are in the development stage and have not been approved for use in humans by any regulatory agency.

Rootine

Seed Round in 2021
Rootine is a precision nutrition platform with evidence-based technology that analyzes biometric and lifestyle data to create individualized nutrition recommendations.

VitaminLab

Series A in 2023
VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry.
Deep Branch Biotechnology is developing scalable technology that transforms the polluters of today into the producers of tomorrow. They generate clean, nutritious and sustainable single cell protein directly from carbon dioxide present in industrial waste gas, thereby reducing the carbon footprint of emitters and providing sustainable alternatives to soy and fishmeal for the feed industry.

NutriLeads

Seed Round in 2015
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.
RayCatch Ltd. develops an automated SaaS system which analyzes the grid's data and provides instructions for optimizing the maintenance and efficiency of the grid. The company is based in Israel.

Meatable B.V.

Series A in 2021
Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world's appetite for meat without harming people, animals, and the planet. It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.

OK Capsule

Seed Round in 2022
OK Capsule is a provider of an online supply chain and product development software for the life science industry. Its enterprise supplement personalization platform provides custom-branded rolls of supplement packets that are more cost-effective than bottles and sustainable for the planet and are made using supplements that are ethnically sourced, fair trade, organic, kosher or halal, non-GMO and dairy, glyphosate, and soy-free that enable businesses to scale the delivery of individualized, premium-grade supplement packets to their customers that is safe for the environment and sustainable.

Chinova Bioworks Inc.

Series A in 2022
Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

ATRO Medical B.V.

Venture Round in 2021
ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise has created the base for the Trammpolin design and the development towards a prototype.

Blue Prairie Brands LLC

Series A in 2016
Blue Prairie Brands is introducing innovative ingredients and related food products rich in prebiotics, which in conjunction with probiotics, help maintain a healthy digestive system. It's flagship product is rich in the prebiotic inulin, yet Blue Prairie Brands delivers it in a whole-food, gluten-free, non-GMO form. The Company's proprietary approach to production also provides farmers a profitable rotation crop that utilizes their existing equipment and experience.

Rootine

Series A in 2022
Rootine is a precision nutrition platform with evidence-based technology that analyzes biometric and lifestyle data to create individualized nutrition recommendations.

OK Capsule

Seed Round in 2021
OK Capsule is a provider of an online supply chain and product development software for the life science industry. Its enterprise supplement personalization platform provides custom-branded rolls of supplement packets that are more cost-effective than bottles and sustainable for the planet and are made using supplements that are ethnically sourced, fair trade, organic, kosher or halal, non-GMO and dairy, glyphosate, and soy-free that enable businesses to scale the delivery of individualized, premium-grade supplement packets to their customers that is safe for the environment and sustainable.

Sciona

Series A in 2002
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Viocare

Venture Round in 2009
Viocare, Inc. is a privately-held company bringing the benefits of cutting edge knowledge in the nutrition and behavior change sciences to the development of breakthrough web and mobile solutions that serve both researchers and the preventive care market.

NutriLeads

Series B in 2020
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

WattGlass LLC

Series A in 2017
WattGlass is a startup company based in Fayetteville, Arkansas. The company was founded to commercialize a novel nanoparticle glass coating developed at the University of Arkansas. The coating technology was invented by our CEO during his PhD research at the University of Arkansas and WattGlass has secured an exclusive license and overseen the filing of a PCT patent application in March 2014. The ongoing research at WattGlass has resulted in the development of additional patent filings related to our core technology.
Leading Edge Crystal Technologies, Inc. engages in the development and manufacturing of silicon wafers that fit into existing module manufacturing processes without any changes. The company was founded in 2016 and is based in Gloucester, Massachusetts.

Chromatic 3D Materials

Series A in 2018
For the first time ever, manufacturers will have the materials required to build durable, functional designs. Chromatic 3D Materials is inventing the next generation of 3D printing materials with the durability to meet the requirements for finished manufactured goods. Today, our reality includes infinite possibilities for novel product designs, made possible by our customizable property range. The scope of destinations for these technologies is vast.
Leading Edge Crystal Technologies, Inc. engages in the development and manufacturing of silicon wafers that fit into existing module manufacturing processes without any changes. The company was founded in 2016 and is based in Gloucester, Massachusetts.

Phytolon

Series A in 2022
Phytolon is a food and beverage company that offers a technology designed for the production of natural food colorants using bakers yeast cells as bio-factory. It specializes in fermentation to create a natural food colorant.

Voxel8

Series B in 2019
Voxel8 Inc. designs and manufactures electronic devices. It offers desktop 3D printers that are used to print thermoplastics or UV resins. The company also provides Project Wire, a cloud software tool that is used for designing 3D printable electronic devices that can be rapidly fabricated using the Voxel8 3D printer. Voxel8 Inc. was incorporated in 2013 and is based in Somerville, Massachusetts.
AMT’s technology is developed at the intersection of material science, chemistry, hardware engineering, robotics and machine learning. Our current focus is on the post processing of 3D printed parts for high volume end use applications across various industrial sectors. Made for companies scaling up their additive manufacturing facilities into high volume production lines. Performance and reliability benchmark, enhancing 3D printed parts to market-ready specifications in a seamless digital workflow.

Frontier Nutrition

Series B in 2021
Frontier Nutrition develop, manufacture, and market packaged food products. They develop, manufacture, and market innovative and exciting products that address the critical needs of millions of families in low income communities around the world. Their products and strategies are based on cutting-edge research in pediatric nutrition and behavioral marketing. Their recipes are localized for traditional diets and optimized for taste, nutrition, and price.

Bio2 Technologies

Venture Round in 2021
Bio2 Technologies (Woburn, MA) is a privately-held medical device company applying CLM™, a propriety Cross-Linked Microstructure fiber bonding process, to produce a range of biocompatible materials with broad application in musculoskeletal clinical practice. Along with offering superior mechanical and biological properties, CLM Technology allows the use of rapid, low cost component fabrication methods.

Micromuscle

Venture Round in 2006
Micromuscle AB was founded in 2000 to develop innovative biomedical products based on the company's proprietary electroactive polymer technology-MICROMUSCLE technology. Micromuscle's proprietary technology relates to electroactive polymers which are capable of expanding and contracting when subjected to an electric potential.

Isobionics

Venture Round in 2014
Isobionics B.V. develops, produces, and sells natural products for customers in flavor and fragrance market. It produces compounds, such as citrus oils that include lemon, orange, and grapefruit; compounds, including valencene and nootkatone, menthol, sandalwood oil, and patchouli oil; and other basic building blocks for the flavor and fragrance industry. The company was founded in 2008 and is based in Geleen, the Netherlands. As of September 26, 2019, Isobionics B.V. operates as a subsidiary of BASF SE.

Segetis

Series B in 2010
Segetis, Inc., a green chemistry company, engages in the development, production, and commercialization of renewable polymers. The company focuses on a platform of binary monomers based on renewable feed stocks. The company's technology enables the use of non-food agricultural and forestry feed stocks for the production of various materials, as well as enables the second wave of industrial bioproducts, such as bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other compounds for specialty chemical applications. Its chemistries offer various opportunities for product enablement and synergies for industries engaged in the processing of starch and sugar crops; processing of wood, cellulose, and paper pulp; chemical processing of vegetable oils; manufacturing of biodiesel; and the manufacturing of linear alpha-olefins and other compounds. The company was founded in 2006 and is based in Golden Valley, Minnesota.

Phynova Group

Venture Round in 2020
Phynova is a British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants. Founded in 2002, Phynova is an innovative life science company based in Oxford, UK with a subsidiary research company located in Beijing, China. Phynova develops and commercialises natural healthcare products derived from active compounds found in plants. Phynova develops products for use in global healthcare and FMCG markets. It identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops solutions for global health concerns.

Morphotek

Series C in 2004
Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Voxel8

Series B in 2019
Voxel8 Inc. designs and manufactures electronic devices. It offers desktop 3D printers that are used to print thermoplastics or UV resins. The company also provides Project Wire, a cloud software tool that is used for designing 3D printable electronic devices that can be rapidly fabricated using the Voxel8 3D printer. Voxel8 Inc. was incorporated in 2013 and is based in Somerville, Massachusetts.

QD Solar

Series A in 2017
The solar photovoltaic market is one of the fastest growing energy markets in the world. That growth comes amidst the race to the bottom on cell and module pricing driven by fierce supply side market competition. PV manufacturers can no longer count on economies of scale and incremental process improvements to attain profit in the face of competitive pricing pressures. Manufacturers need to differentiate their product by delivering better performance for the same or lower cost. QD Solar, a University of Toronto spinoff company, will provide this differentiation.

Novomer, Inc.

Series B in 2009
Novomer is a new materials company pioneering a family of competitively priced high-performance green plastics, polymers and other chemicals. With proprietary catalytic technology and a world-class scientific team, Novomer's groundbreaking technology allows carbon dioxide and other renewable materials to be cost-effectively transformed into polymers, plastics and other chemicals for a wide variety of industrial markets. It was founded in 2004 and headquartered in Waltham, Massachusetts.

Tespo

Series A in 2018
At Tespo, they create innovative products for customers to help improve their quality of life and deliver an experience that exceeds their expectations. Tespo’s system provides all the storage, convenience and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives or unnecessary ingredients. By leveraging a disc/dispenser design - Tespo provides an individual liquid vitamin serving everyday delivered straight to your door each month.

ZeaVision

Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.

Chinova Bioworks Inc.

Seed Round in 2018
Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

Arecor

Venture Round in 2016
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

Verdezyne

Venture Round in 2011
Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.

NovoPolymers NV

Venture Round in 2015
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Xolve

Funding Round in 2012
Xolve, Inc., a nanomaterials company, produces and supplies graphene that is used to improve the properties of various industrial plastics for use in automotive, aerospace, electronics, and other applications. It offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene. Xolve, Inc. was formerly known as Graphene Solutions, Inc. and changed its name to Xolve, Inc. in September 2010. The company was founded in 2008 and is based in Middleton, Wisconsin. As of March 31, 2016, Xolve, Inc. operates as a subsidiary of Reliance Industries Limited.

Sciona

Series B in 2004
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Cellmade SAS

Funding Round in 2010
Cellmade SAS operates as a biopharmaceutical company. The company develops and supplies cell biology products such as blood cells, endothelial cells, epithelial cells, fibroblasts, hepactocytes, adipocytes, inflammatory and cardiovascular cells, pancreatic cells, skeleton muscle cells, and laboratory services, which includes biobank, cell based assays, cytometry, and mass spectrometry. Cellmade SAS was founded in 2007 and is based in Chappes, France with an additional location in Ruffieux, France.

Verdezyne

Venture Round in 2014
Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.
Food Quality Sensor International, Inc. operates as a sensor technology company. It develops and commercializes real-time and interactive food freshness measurement devices. The company provides SensorQ, which measures the level of freshness of meat or poultry within the package; and SensorfreshQ, a handheld electronic nose that detects meat and poultry spoilage. It serves food processing, grocery distribution, food service, regulatory, defense, and consumer retail markets. The company was incorporated in 2004 and is headquartered in Lexington, Massachusetts.

ChromaDex

Post in 2013
ChromaDex Corporation operates as a nutraceutical company. The company offers Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide (NAD) level used for healthy aging; and Immulina, a spirulina extract and compound, which is used for improving human immune function. It also provides reference standards and fine chemicals to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, and pharmaceutical industries. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation is headquartered in Los Angeles, California.

IntegraGen SA

Venture Round in 2006
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

Miach Orthopaedics

Series A in 2018
Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury. Miach Orthopaedics was founded on 2016 and is headquartered in Westborough, Massachusetts.
Leading Edge Crystal Technologies, Inc. engages in the development and manufacturing of silicon wafers that fit into existing module manufacturing processes without any changes. The company was founded in 2016 and is based in Gloucester, Massachusetts.

Panaceutics Inc.

Series A in 2020
Panaceutics Inc. engages in formulation, manufacturing, and distribution of medicines. The company offers technology to transform multiple pills into a single packet of easy-to-swallow fruit puree for macro nutrient needs. It serves to healthcare systems, integrated delivery partners, pharmaceutical companies, and nutritional product manufacturers. The company was founded in 2013 and is based in Research Triangle Park, North Carolina.

Provexis

Post in 2008
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company’s syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Essential Medical

Series B in 2016
Essential Medical, Inc. has developed two femoral artery closure devices intended to seal femoral punctures following vascular access medical procedures requiring a cardiac catheterization. MANTA is designed to close large bore punctures (10-24F) following procedures such as transcatheter aortic valve replacement (TAVR), abdominal aortic aneurysm repair (AAA/PVAR), and balloon aortic valvuloplasty (BAV). These procedures are one of the fastest growing segments within interventional cardiology.

Sciona

Series C in 2006
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Regentis Biomaterials

Series C in 2012
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The company’s core technology is a iodegradable hydrogel called Gelrin™. It is based on polyethylene glycol diacrylate and denatured fibrinogen originally developed at the Technion University by Dr. Dror Seliktar. The Gelrin hydrogel platform combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications and has undergone extensive preclinical and safety testing over the last few years. The company’s flagship product, GelrinC™,designed for the treatment of articular cartilage lesions, is currently in clinical trials.

Arecor

Venture Round in 2013
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

Upfront Chromatography

Venture Round in 2007
Upfront Chromatography is a Denmark-based biotech company with significant expertise and regulatory experience in the development of customised industrial processes. Upfront develops and manufactures innovative products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells, directly from bioreactors and industrial side-streams.

Chinova Bioworks Inc.

Seed Round in 2019
Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.
AMT’s technology is developed at the intersection of material science, chemistry, hardware engineering, robotics and machine learning. Our current focus is on the post processing of 3D printed parts for high volume end use applications across various industrial sectors. Made for companies scaling up their additive manufacturing facilities into high volume production lines. Performance and reliability benchmark, enhancing 3D printed parts to market-ready specifications in a seamless digital workflow.

Harland Medical Systems

Private Equity Round in 2007
Increasing the value of healthcare products with integrated surface enhancement solutions Harland Medical Systems was founded in 2003 in Minnesota, USA to bring total solutions to the emerging healthcare surface enhancement market. Since that time we have dozens of successful customer installations under our belt, ranging in industry market segments from Neurology to Urology and Cardiology to Wound care, Peripheral, Micro-plate, Ophthalmic, Endoscopic and many others.

Ganeden, Inc.

Venture Round in 2007
Ganeden Biotech was founded in 1997 out of a desire to develop superior strains of probiotics which break down the barriers inherent to most common strains of probiotics. Simply put, Ganeden is a science driven organization dedicated to bringing superior probiotics to markets that have otherwise been unmet by traditional solutions. Through dedication to our mission, "Improving Quality of Life" They are driven to develop solutions that are safe and effective. In 2003 Ganeden launched a popular line of over-the-counter products under brand names such as Digestive Advantage, Clearly Confident and Sustenex. Since launching the consumer product line in 2003 Ganeden' has sold nearly 200 million doses of its products through over 40,000 retail outlets.

Bio2 Technologies

Series C in 2018
Bio2 Technologies (Woburn, MA) is a privately-held medical device company applying CLM™, a propriety Cross-Linked Microstructure fiber bonding process, to produce a range of biocompatible materials with broad application in musculoskeletal clinical practice. Along with offering superior mechanical and biological properties, CLM Technology allows the use of rapid, low cost component fabrication methods.

EyePromise

Venture Round in 2014
EyePromise manufactures and sells zeaxanthin dietary supplements for those at risk of age-related vision loss. It offers QuantifEYE program for assessing risk of developing age-related macular degeneration; EyePromise restore, a professional dietary supplement; and EyePromise ten-for those who prefer xeaxanthin supplement.

Inkbit

Venture Round in 2019
Inkbit creats a next-generation additive manufacturing platform that combines 3D printing with machine vision. MIT-trained scientists and engineers combines expertise in industrial systems, design software, and material science to identify and seize opportunities for mass-market additive manufacturing.

ATRO Medical B.V.

Series A in 2017
ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise has created the base for the Trammpolin design and the development towards a prototype.

Natreon

Venture Round in 2015
Natreon, Inc.is a company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property.

Adaptive3D

Series A in 2019
Adaptive3D is the premium additive manufacturing polymer resin supplier.  They partner with global leaders to deliver solutions for functional end use products and prototypes.

Segetis

Series C in 2012
Segetis, Inc., a green chemistry company, engages in the development, production, and commercialization of renewable polymers. The company focuses on a platform of binary monomers based on renewable feed stocks. The company's technology enables the use of non-food agricultural and forestry feed stocks for the production of various materials, as well as enables the second wave of industrial bioproducts, such as bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other compounds for specialty chemical applications. Its chemistries offer various opportunities for product enablement and synergies for industries engaged in the processing of starch and sugar crops; processing of wood, cellulose, and paper pulp; chemical processing of vegetable oils; manufacturing of biodiesel; and the manufacturing of linear alpha-olefins and other compounds. The company was founded in 2006 and is based in Golden Valley, Minnesota.

NOMADD

Series A in 2016
NOMADD develops and provides desert solar panel cleaning solutions. It offers NOMADD (no water mechanical automated dusting device) that is a desert solar panel cleaning system to meet the needs of desert cleaning challenges. The company is headquartered in Saudi Arabia.

Interface Biologics, Inc.

Series B in 2015
Interface Biologics, Inc. (IBI) is a commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. Their patent-protected technologies include anti-thrombogenic additives for blood contacting medical devices and polymer enabled combination drug delivery devices. IBI has exclusive Endexo™ technology licensing agreements with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic dialysis systems. AngioDynamics’ BioFlo PICCS, Ports and DuraMax Dialysis Catheter with IBI’s Endexo technology have received FDA clearance and are gaining commercial traction. IBI also has a joint venture commercial agreement with Qualimed to develop a drug-coated balloon based on IBI’s Kinesyx™ technology. The company was founded in 2001 and is headquartered in Toronto, Canada at the acclaimed MaRS Innovation Centre.

Panaceutics Inc.

Venture Round in 2019
Panaceutics Inc. engages in formulation, manufacturing, and distribution of medicines. The company offers technology to transform multiple pills into a single packet of easy-to-swallow fruit puree for macro nutrient needs. It serves to healthcare systems, integrated delivery partners, pharmaceutical companies, and nutritional product manufacturers. The company was founded in 2013 and is based in Research Triangle Park, North Carolina.

ORYXE Energy International

Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.